Back

Subtherapeutic activated clotting time after pre-hospital unfractionated heparin in ST-elevation myocardial infarction

28 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: New frontiers in acute coronary syndromes: artificial intelligence, haemodynamics, and prognosis ST-Elevation Myocardial Infarction (STEMI) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Inge Tessa Bosch

Academic Medical Centre, Amsterdam (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Multimodal large language models miss two-thirds of STEMIs on electrocardiograms and concentrate false-positive diagnoses in STEMI mimics and normal tracings
Doctor H. Kamalanathan (Sydney, AU)
Abstract Slides Video
Presentation thumbnail
Impact of concomitant aortic stenosis on in-hospital outcomes in non-ST-elevation myocardial infarction
Mr J. Altstidl (Erlangen, DE)
Abstract Slides Video
Presentation thumbnail
Robust diagnostic performance of artificial intelligence–enabled electrocardiography across heterogeneous NSTEMI presentations: a prospective multicenter analysis
Doctor M. Lee (Bucheon, KR)
Abstract Slides Video
Presentation thumbnail
Percutaneous coronary intervention in late-presenting acute myocardial infarction without myocardial viability: effects on left ventricular remodeling and function by cardiac magnetic resonance
Doctor B. Valente (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Prognostic performance of the InterTAK Score in a nationwide Takotsubo syndrome registry
Doctor J. Larre Guerra (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
New frontiers in acute coronary syndromes: artificial intelligence, haemodynamics, and prognosis

The Event

Event poster

ESC Congress 2026

28 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Should every suspected ACS patient receive pre-hospital aspirin and heparin-bolus?
10 March 2024
thumbnail
Congress Presentation
Comparison of mechanical/optical and microfluidic electrochemical point-of-care ACT systems during transseptal ablation under continuous anticoagulation
12 April 2026
thumbnail
Congress Presentation
Is spontaneous pre-hospital coronary reperfusion in STEMI safe ?
1 September 2025
thumbnail
Congress Presentation
Platelet reactivity and activated clotting time predict haemorrhagic site complications in patients with chronic coronary syndromes undergoing percutaneous coronary intervention
26 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources